In the Journals

Concurrent NASH drives a ‘second hit’ to the liver in patients with HBV

July 19, 2019
Recent study data showed that concomitant chronic hepatitis B and nonalcoholic steatohepatitis were significantly more likely to lead to advanced…
Feature

AASLD Foundation presents grants to young hepatologists for research, careers

July 18, 2019
The American Association for the Study of Liver Diseases Foundation has granted $3.42 million in research and career development awards to 29…

InSphero launches NAFLD, NASH cellular drug development platform

July 18, 2019
InSphero AG announced the launch of 3D InSight Human Liver Disease Discovery Platform, a 3D cell technology for development and safety testing of…

FDA offers tips on advising patients how to dispose of unneeded medications

July 18, 2019
Proper disposal of unused prescription medication remains a major public health priority for the FDA, particularly for prescription opioid pain
Cover Story

Defining the Roadmap to Success for Patients With Alcohol-Related Liver Disease

Healio Gastroenterology, July 2019
Humans have enjoyed the intoxicating effects of alcohol as early as the Neolithic period around 10,000 BC. Unfortunately, research also suggests that…
Guest Editorial

Addressing Problematic Drinking in Liver Disease by ‘Opening the Conversation’

Healio Gastroenterology, July 2019
Treating alcohol-related liver disease doesn’t start or stop with the liver. When I talk to my patients with alcohol use disorder, I tell them…
In the Journals

Harvoni joins growing DAA options for younger patients with HCV

July 17, 2019
Harvoni joins other direct-acting antivirals in demonstrating safety and high efficacy in younger pediatric patients with chronic hepatitis C…
Feature

Telemedicine takes focus in study of HCV treatment in methadone centers

July 17, 2019
With $7 million from the Patient-Centered Outcomes Research Institute, seven opioid treatment programs announced entry into an ongoing study of…
In the Journals

Living donor LT provides better survival, lower costs vs. deceased donors

July 16, 2019
Living donor liver transplantation showed multiple superior outcomes compared with deceased donor liver transplantation, including longer survival…

NASH update: Expert opinions on awareness, potential therapeutics

July 15, 2019
Many experts consider the rising rates of nonalcoholic steatohepatitis to be nearing “epidemic levels” and, as such, will require…
In the Journals

Population density, water balance influence hepatitis E outbreaks

July 15, 2019
Researchers found that population density and water balance were key factors influencing the occurrence of hepatitis E outbreaks, according to a…
In the JournalsPerspective

Pharmacist-driven HCV treatment model yields high SVR rates

July 14, 2019
Clinical pharmacist-delivered hepatitis C virus therapy yields high rates of SVR, according to findings published in Open Forum Infectious
Meeting News

Opioids’ negative consequences extend to patients with migraine, expert says

July 14, 2019
PHILADELPHIA — The benefits of prescribing opioids to patients with migraines usually do not outweigh the risk, a past president of the…

$1.4 billion lawsuit, largest against opioid manufacturer, settles before trial

July 12, 2019
A lawsuit filed against London-based Reckitt Benckiser Group plc was recently settled for $1.4 billion, the largest settlement to date against an…
In the Journals

Liver fat biomarker decreases after exercise, improving metabolic profile

July 11, 2019
Levels of dimethylguanidino valeric acid, a metabolite that was recently determined to be a circulating biomarker of liver fat, correlated with…

Maralixibat bile acid inhibitor enters phase 3 trial for pediatric PFIC

July 11, 2019
Mirum Pharmaceuticals dosed the first patient in a phase 3 trial of maralixibat, its lead drug candidate for the treatment of pediatric patients with…

HCV micro-elimination program seeks to cure high-risk Kentucky county

July 11, 2019
Intent Solutions announced a partnership with the University of Kentucky in a $15 million federal grant program aimed at eliminating hepatitis C in…
Meeting News

Opioid use among patients with migraine ‘alarmingly high’

July 11, 2019
PHILADELPHIA — Opioid use continues to be “major issue” in adults with migraine, despite practices discouraging patients from using…
In the Journals

In AF, liver disease confers elevated bleeding risk after anticoagulation

July 11, 2019
Major bleeding risk was elevated in patients with atrial fibrillation and a history of liver disease after the use of oral anticoagulants, according…
In the Journals

VCTE superior marker for measuring fibrosis in patients with HBV/HIV

July 10, 2019
Vibration-controlled transient elastography outperformed aspartate aminotransferase to platelet ratio index and Fibrosis-4 index as a noninvasive…